|
1
|
Chen Q, Sousa JD, Snowise S, Chamley L and
Stone P: Reduction in the severity of early onset severe
preeclampsia during gestation may be associated with changes in
endothelial cell activation: A pathological case report. Hypertens
Pregnancy. 35:32–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGinnis R, Steinthorsdottir V, Williams
NO, Thorleifsson G, Shooter S, Hjartardottir S, Bumpstead S,
Stefansdottir L, Hildyard L, Sigurdsson JK, et al: FINNPEC
Consortium; GOPEC Consortium: Variants in the fetal genome near
FLT1 are associated with risk of preeclampsia. Nat Genet.
49:1255–1260. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li XL, Chen TT, Dong X, Gou WL, Lau S,
Stone P and Chen Q: Early onset preeclampsia in subsequent
pregnancies correlates with early onset preeclampsia in first
pregnancy. Eur J Obstet Gynecol Reprod Biol. 177:94–99. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mol BWJ, Roberts CT, Thangaratinam S,
Magee LA, de Groot CJM and Hofmeyr GJ: Pre-eclampsia. Lancet.
387:999–1011. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rana S, Karumanchi SA and Lindheimer MD:
Angiogenic factors in diagnosis, management, and research in
preeclampsia. Hypertension. 63:198–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levron Y, Dviri M, Segol I, Yerushalmi GM,
Hourvitz A, Orvieto R, Mazaki-Tovi S and Yinon Y: The ‘immunologic
theory’ of preeclampsia revisited: a lesson from donor oocyte
gestations. Am J Obstet Gynecol. 211(383): e1–e5. 2014.
|
|
7
|
Meeme A, Buga GA, Mammen M and Namugowa A:
Endothelial dysfunction and arterial stiffness in pre-eclampsia
demonstrated by the EndoPAT method. Cardiovasc J Afr. 28:23–29.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chaiworapongsa T, Chaemsaithong P, Yeo L
and Romero R: Pre-eclampsia part 1: Current understanding of its
pathophysiology. Nat Rev Nephrol. 10:466–480. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Zhou WH, Ren L and Zhang YZ: CXCR4,
CXCR7, and CXCL12 are associated with trophoblastic cells apoptosis
and linked to pathophysiology of severe preeclampsia. Exp Mol
Pathol. 100:184–191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Zuylen WJ, Ford CE, Wong DD and
Rawlinson WD: Human cytomegalovirus modulates expression of
noncanonical Wnt receptor ROR2 to alter trophoblast migration. J
Virol. 90:1108–1115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
August P and Sibai BM: Preeclampsia:
Clinical Features and DiagnosisLockwood CJ and Barss VA: UpToDate.
Waltham, MA: 2015, https://www.uptodate.com/contents/preeclampsia-clinical-features-and-diagnosis
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. METHODS. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karakus S, Bagci B, Bagci G, Sancakdar E,
Yildiz C, Akkar O and Cetin A: SDF-1/CXCL12 and CXCR4 gene
variants, and elevated serum SDF-1 levels are associated with
preeclampsia. Hypertens Pregnancy. 36:124–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Myatt L, Redman CW, Staff AC, Hansson S,
Wilson ML, Laivuori H, Poston L and Roberts JM: Global Pregnancy
CoLaboratory: Strategy for standardization of preeclampsia research
study design. Hypertension. 63:1293–1301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dodd JM, O'Brien C and Grivell RM:
Preventing pre-eclampsia - are dietary factors the key? BMC Med.
12:1762014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bramham K, Seed PT, Lightstone L,
Nelson-Piercy C, Gill C, Webster P, Poston L and Chappell LC:
Diagnostic and predictive biomarkers for pre-eclampsia in patients
with established hypertension and chronic kidney disease. Kidney
Int. 89:874–885. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Stepan H, Herraiz I, Schlembach D,
Verlohren S, Brennecke S, Chantraine F, Klein E, Lapaire O, Llurba
E, Ramoni A, et al: Implementation of the sFlt-1/PlGF ratio for
prediction and diagnosis of pre-eclampsia in singleton pregnancy:
Implications for clinical practice. Ultrasound Obstet Gynecol.
45:241–246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Käehne LV and Lundin ICR: Treatment with
low-dose acetylsalicylic acid can reduce risk of pre-eclampsia in
high-risk pregnant women. Ugeskr Laeger. 179:20172017.(In
Danish).
|
|
19
|
Rolnik D, Wright D, Poon L, O'Gorman N,
Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D,
Singh M, et al: OC01. 04: Aspirin versus placebo in pregnancies at
high-risk of preterm pre-eclampsia: A multicentre, double-blind,
placebo-controlled trial. Ultrasound Obstet Gynecol. 50:1–47. 2017.
View Article : Google Scholar
|
|
20
|
Rouskin S, Zubradt M, Washietl S, Kellis M
and Weissman JS: Genome-wide probing of RNA structure reveals
active unfolding of mRNA structures in vivo. Nature. 505:701–705.
2014. View Article : Google Scholar : PubMed/NCBI
|
